| Our latest Quality Matters news brief features an article touching on the OhioHealth system's response to the paclitaxel controversy—almost one year ago, now—a QUICK response which gives us great insight into how to respond to future uncertainties and engage multi-disciplinary teams in ensuring patient safety and promoting quality care.
Gary Ansel, MD of OhioHealth described how this large system called for an immediate moratorium on the devices while engaging a multi-disciplinary team to review the evidence. "I can tell you we went over the published literature in detail," said Dr. Ansel. "It was refreshing for all of us to see the politics leave and just focus on the patients."
Dr. Ansel's insight here reinforces the value of multi-disciplinary teams focused on outcomes. Solid quality review and continuous quality improvement processes can not only improve patient care and provider excellence, but they can also help hospitals and systems be quick to act in cases of uncertainty like that of the paclitaxel debate.
Accreditation for Cardiovascular Excellence can provide some often much-needed external impetus, support and validation for your organization to establish sustainable and robust quality improvement processes.
|
